Device / Technology News

RSS

Caliper Life Sciences releases Living Image 4.0 software for its IVIS in vivo imaging systems

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 software for IVIS® in vivo imaging systems. Living Image software drives the more than 800 Caliper IVIS systems currently installed in laboratories worldwide.

3 Dec 2009

NIMS’ Exer-Rest acceleration therapeutic platform granted Canadian Patent

Non-Invasive Monitoring Systems, Inc. announced that the Canadian Patent Office issued Patent number 2,534,302 to NIMS on October 20, 2009. The patent, entitled “Reciprocating Movement Platform for the External Addition of Pulses to the Fluid Channels of a Subject”, relates to the comprehensively researched technology underlying NIMS’ Exer-Rest acceleration therapeutic platform.

3 Dec 2009

Spectranetics receives FDA clearance for its new VisiSheath Dilator Sheath device

Spectranetics Corporation today announced it has received Food and Drug Administration (FDA) 510(k) clearance for its new VisiSheathTM Dilator Sheath device. This expands the market for VisiSheath, which recently also received CE Mark approval in Europe.

3 Dec 2009

GTSI named value-added reseller of the Intel Health Guide RPM solution

GTSI Corp. an enterprise technology solutions and services provider was recently named a value-added reseller to deliver the Intel® Health Guide, a comprehensive, next-generation remote patient monitoring (RPM) solution that combines an in-home patient device, the Intel Health Guide PHS6000, with the Intel® Care Management Suite, an online interface that allows clinicians to monitor patients and remotely manage care.

3 Dec 2009

Milestone Scientific announces new joint venture with two PRC pharmaceutical companies

Milestone Scientific Inc., the recognized leader in advanced injection technologies, today announced that it had entered into a joint venture with China National Medicines Corporation Ltd. (d/b/a "Sinopharm") and Yichang Humanwell Pharmaceutical Co. Ltd., both incorporated in the People's Republic of China (the "PRC"), to develop orthopedic and epidural drug delivery instruments.

3 Dec 2009

New health IT grants to be 'models' for the nation

The federal government will offer $235 million in grants for communities to upgrade and improve their health information technology, The Dallas Morning News reports. Only organizations that are already using health IT are eligible. Health secretary Kathleen Sebelius said, "Our hope is that the communities will become models for the rest of the country" (Roberson, 12/2).

3 Dec 2009

CLC bio, imaGenes announce collaboration in high-throughput sequencing analyses

Today, the leading provider of High-Throughput Sequencing analysis solutions, CLC bio, announced that they're collaborating with premier German sequencing service provider, imaGenes, to better support the fast growing German market of high-throughput sequencing analyses. imaGenes, will provide all customers receiving Next Generation Sequencing data with a temporary license for CLC Genomics Workbench for assembly and downstream sequence analyses.

3 Dec 2009

Cielo MedSolutions, DrFirst partner to provide a comprehensive e-prescribing solution

Cielo MedSolutions today announced a new partnership with DrFirst to provide comprehensive e-prescribing functionality to practices using the company's Cielo Clinic clinical quality management system. The fully integrated e-prescribing solution will enable customers to improve prescribing safety and medical practice efficiency.

3 Dec 2009

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Cubist Pharmaceuticals, Inc. today announced the early closing of enrollment in its ecallantide Phase 2 program. Ecallantide, in development as therapy to reduce bleeding in on-pump cardiac surgery, is now known as CB-500,929. After a regularly scheduled review meeting, the Data Safety Monitoring Board (DSMB) contacted the company to recommend a temporary suspension in enrollment in one of the CB-500,929 trials, CONSERV-2.

3 Dec 2009

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Rules-Based Medicine, Inc. (RBM) today announced that Psynova Neurotech Limited (Cambridge UK), a majority-owned subsidiary of RBM, has executed an exclusive research and licensing agreement with Roche to collaborate on the discovery, development, validation and commercialization of diagnostic immunoassays to aid the clinical development and commercial differentiation of novel treatments for schizophrenia.

3 Dec 2009

Continued rise of PSA value in prostate cancer patients can indicate relapsing disease

Prostate cancer patients who have a prostate-specific antigen (PSA) value of less than or equal to 1.5 at two years after external beam radiation therapy (EBRT) are less likely to have a cancer recurrence and cancer-related death, according to a study in the December 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

3 Dec 2009

Most of the fatal falls in the home can be avoided with fall prevention and protection products

Healthcare costs are rapidly increasing due to the rapid aging of our population. The Center for Disease Control and Prevention indicates that over 60% of fatal falls occur in the home. Additionally, the total cost of falls in 2010 is expected to be between 68 and 100 Billion Dollars. More than 25,000 older adults died due to falls last year.

3 Dec 2009

MaRS teams up with Baycrest to develop and market brain fitness products

One of the world's leading cognitive science institutes announced today it has created a new company with MaRS, Canada's premiere innovation centre, to develop and market brain fitness products to help adults extend their memory and cognitive abilities longer in the lifespan.

3 Dec 2009

Roche to provide the RealTime ready Influenza A/H1N1 Detection Set to CLIA high-complexity labs under EUA

The Roche assay for the 2009 H1N1 influenza virus detects RNA from the 2009 H1N1 Influenza A virus and provides a rapid means of identification of patients infected with this virus. In order to ensure continued specificity and sensitivity of the Roche's Influenza A/H1N1 assay, Roche performs sequence comparisons with all available 2009 H1N1 Influenza Virus sequences on a regular basis.

3 Dec 2009

Specially developed PACEM system installed at Max Planck Institute for Biophysics

PACEM is a transmission electron microscope (TEM) designed to image low-contrast biological specimens. It was specially developed and installed at the Max Planck Institute for Biophysics (MPI-BP) by optical expert Carl Zeiss in Oberkochen and researchers from the Macromolecular Complexes excellence cluster in Frankfurt.

3 Dec 2009

Lung disease linked to the use of contaminated well water in a CPAP machine

Many people rely on continuous positive airway pressure (CPAP) machines as a safe and effective treatment for sleep apnea. But a new case report describes a rare complication—a lingering inflammatory disease of the lungs, apparently related to the use of contaminated well water in a CPAP machine. The report appears in the December Southern Medical Journal, official journal of the Southern Medical Association.

3 Dec 2009

New study utilizes solid-state NMR spectroscopy to analyze intact bone

A new study using solid-state NMR spectroscopy to analyze intact bone paves the way for atomic-level explorations of how disease and aging affect bone.

3 Dec 2009

Novel multi-analyte approach to develop urine-biomarker based diagnostic assay to be presented

Predictive Biosciences today announced that Company scientists will be presenting a novel multi-analyte approach to the development of a non-invasive, urine-biomarker based diagnostic assay during the 10th Annual Meeting of the Society of Urologic Oncology (SUO).

3 Dec 2009

AclarusDx Alzheimer’s test now available as RUO product

ExonHit Therapeutics is pleased to announce that AclarusDx™ Alzheimer’s test (formerly known as EHT Dx21), its blood-based test for the detection of Alzheimer’s disease (AD), is now available as a Research Use Only (RUO) product for pharmaceutical companies and leading academic centers conducting clinical trials in Alzheimer’s disease.

3 Dec 2009

First computerized crash model to test how crash forces affect the human body

Although states are not required to report fetal deaths in accident data, between 300 and 1,000 unborn babies die in car accidents each year. This accident fatality rate is about four times the rate for victims between infancy and four years old, said Stefan Duma, head of the Virginia Tech --- Wake Forest University School of Biomedical Engineering and Science (SBES).

3 Dec 2009

Device / Technology News

Caliper Life Sciences releases Living Image 4.0 software for its IVIS in vivo imaging systems

NIMS’ Exer-Rest acceleration therapeutic platform granted Canadian Patent

Spectranetics receives FDA clearance for its new VisiSheath Dilator Sheath device

GTSI named value-added reseller of the Intel Health Guide RPM solution

Milestone Scientific announces new joint venture with two PRC pharmaceutical companies

New health IT grants to be 'models' for the nation

CLC bio, imaGenes announce collaboration in high-throughput sequencing analyses

Cielo MedSolutions, DrFirst partner to provide a comprehensive e-prescribing solution

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Continued rise of PSA value in prostate cancer patients can indicate relapsing disease

Most of the fatal falls in the home can be avoided with fall prevention and protection products

MaRS teams up with Baycrest to develop and market brain fitness products

Roche to provide the RealTime ready Influenza A/H1N1 Detection Set to CLIA high-complexity labs under EUA

Specially developed PACEM system installed at Max Planck Institute for Biophysics

Lung disease linked to the use of contaminated well water in a CPAP machine

New study utilizes solid-state NMR spectroscopy to analyze intact bone

Novel multi-analyte approach to develop urine-biomarker based diagnostic assay to be presented

AclarusDx Alzheimer’s test now available as RUO product

First computerized crash model to test how crash forces affect the human body

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News